PRINCIPAL BIOSTATISTICIAN
Centre for Biostatistics and Clinical Trials
at the Peter MacCallum Cancer Centre in Melbourne, Australia
Centre for Biostatistics and Clinical Trials (BaCT) at the Peter MacCallum Cancer Centre in Melbourne, Australia is seeking a full-time Principal Biostatistician with a very strong statistical leadership, project management and research track record. The successful applicant will lead a dedicated team of biostatisticians involved in design, analysis and reporting of cancer clinical trials and other clinical research projects.
BaCT provides a unique and exciting opportunity for an experienced biostatistician interested in cancer research to be at the forefront of cancer treatment, research and education. For information about the department, see http://www.petermac.org/CentreforBiostatisticsandClinicalTrials <http://www.petermac.org/CentreforBiostatisticsandClinicalTrials>
Applications which include a statement addressing selection criteria and a curriculum vitae should be received by Friday 27 November 2009 via email to [log in to unmask] <mailto:[log in to unmask]> . Enquiries can be addressed to Dr Dina Neiger (+61 3 9656 1917; [log in to unmask] <mailto:[log in to unmask]> ).
Selection criteria for the position are available on the Peter Mac website (http://www.petermac.org/PositionsVacant). Opportunities for a sabbatical position are available.
This email (including any attachments or links) may contain
confidential and/or legally privileged information and is
intended only to be read or used by the addressee. If you
are not the intended addressee, any use, distribution,
disclosure or copying of this email is strictly
prohibited.
Confidentiality and legal privilege attached to this email
(including any attachments) are not waived or lost by
reason of its mistaken delivery to you.
If you have received this email in error, please delete it
and notify us immediately by telephone or email. Peter
MacCallum Cancer Centre provides no guarantee that this
transmission is free of virus or that it has not been
intercepted or altered and will not be liable for any delay
in its receipt.
|